We hypothesize that poor PON1 activity is associated with vascular damage evidenced by increased levels of circulating ICAM-1 and VCAM-1 leading to higher disease burden in IIM and IIM associated ILD, particularly in the DM subtype. Here, ICAM1 is linked to dermatomyositis.